Dexcel PT Israel Ltd - Strategic SWOT Analysis Review

November 2021 | 22 pages | ID: D53EE73E992EN
GlobalData

Abstracts

Dexcel PT Israel Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Dexcel PT Israel Ltd (Dexcel Pharma), a subsidiary of Dexcel PT Holdings Ltd develops, manufactures and markets branded and generic pharmaceuticals in various dosage forms. Its major products include PerioChip (chlorhexidine gluconate), a non-antibiotic adjunct treatment for scaling and root planning and adult periodontitis; Deximune, an immunosuppressant; and omeprazole delayed released tablet for the treatment of gastroesophageal reflux disease, peptic ulcer disease, and Zollinger–Ellison syndrome. It also offers products for cardiovascular disorders, dental diseases, allergy, pain relief, and skin diseases, among others. Dexcel Pharma develops formulations using proprietary, patent-protected, drug delivery technologies. It sells its products through a network of subsidiaries, distributors in Western Europe. Dexcel Pharma is headquartered in Or Akiva, Haifa, Israel.

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Dexcel PT Israel Ltd - Key Facts
Dexcel PT Israel Ltd - Key Employees
Dexcel PT Israel Ltd - Major Products and Services
Dexcel PT Israel Ltd - History
Dexcel PT Israel Ltd - Company Statement
Dexcel PT Israel Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Dexcel PT Israel Ltd - Business Description
Dexcel PT Israel Ltd - SWOT Analysis
SWOT Analysis - Overview
Dexcel PT Israel Ltd - Strengths
Dexcel PT Israel Ltd - Weaknesses
Dexcel PT Israel Ltd - Opportunities
Dexcel PT Israel Ltd - Threats
Dexcel PT Israel Ltd - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Dexcel PT Israel Ltd, Recent Deals Summary

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Dexcel PT Israel Ltd, Key Facts
Dexcel PT Israel Ltd, Key Employees
Dexcel PT Israel Ltd, Major Products and Services
Dexcel PT Israel Ltd, History
Dexcel PT Israel Ltd, Other Locations
Dexcel PT Israel Ltd, Subsidiaries
Dexcel PT Israel Ltd, Key Competitors
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Dexcel PT Israel Ltd, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021